Deregulation of the Rb/E2F pathway in human fibroblasts results in an E2F1-mediated apoptosis dependent on Atm, Nbs1, Chk2 and p53. Here, we show that E2F1 expression results in MRN foci formation, which is independent of the Nbs1 interacting region and the DNA-binding domain of E2F1. E2F1-induced MRN foci are similar to irradiation-induced foci (IRIF) that result from doublestrand DNA breaks because they correlate with 53BP1 and cH2AX foci, do not form in NBS cells, do form in AT cells and do not correlate with cell cycle entry. In fact, we find that in human fibroblasts deregulated E2F1 causes a G1 arrest, blocking serum-induced cell cycle progression, in part through an Nbs1/53BP1/p53/p21 WAF1/CIP1 checkpoint pathway. This checkpoint protects against apoptosis because depletion of 53BP1 or p21 WAF1/CIP1 increases both the rate and extent of apoptosis. Nbs1 and p53 contribute to both checkpoint and apoptosis pathways. These results suggest that E2F1-induced foci generate a cell cycle checkpoint that, with sustained E2F1 activity, eventually yields to apoptosis. Uncontrolled proliferation due to Rb/E2F deregulation as well as inactivation of both checkpoint and apoptosis programs would then be required for transformation of normal cells to tumor cells.
Introduction
In a normal cell, maintenance of genomic integrity and accurate DNA replication are ensured in part due to the tight control of cell cycle progression from G1 to S phase. The proteins primarily responsible for restraining the G1/S transition are the Rb family members, Rb, p107 and p130. In their hypophosphorylated state, these pocket proteins interact with E2F family members. Following a growth stimulus, cyclin-dependent kinases phosphorylate Rb leading to derepression of the activator E2Fs, which can then induce S phase genes required for DNA replication (Cobrinik, 2005) . Deregulation of the Rb/E2F pathway is one of the hallmarks of cancer, which highlights its significant cellular role. Disruption of the pathway can occur due to interference by viral oncoproteins or through mutations in Rb or upstream regulators of Rb such as p16/Ink4a, cyclin D or Cdk4 (Hanahan and Weinberg, 2000) .
In the event of Rb/E2F deregulation and subsequent uncontrolled proliferation, cells have a second level of control provided by the p53 pathway, which responds by inducing a cell cycle arrest or apoptosis. It is therefore not surprising that p53 is also mutated or deleted in a large number of cancers. The p53 pathway is also activated in response to a variety of DNA damage and stress stimuli such as UV irradiation, ionizing radiation and hypoxia (Meek, 2004) . Stimulation of p53 is regulated by multiple pathways including the p14ARF/Mdm2 pathway and by numerous covalent modifications, including phosphorylation (Oren, 2003) . Although p14ARF modulates p53 under certain conditions, it is not required for p53 activation and apoptosis resulting from DNA damage or from inappropriate proliferation signals generated by Rb inactivation or ectopic E2F1 expression (Russell et al., 2002; Tolbert et al., 2002; Tsai et al., 2002; Lindstrom and Wiman, 2003; Rogoff et al., 2002) . Rather, there is a requirement for the DNA damage response proteins Atm, Nbs1 and Chk2 in E2F1-mediated p53-dependent apoptosis (Powers et al., 2004; Rogoff et al., 2004) .
Immediately following DNA damage induced by IR or genotoxic drugs, DNA damage proteins relocalize to sites of the double-stranded DNA breaks, for example, the MRN complex, 53BP1 and gH2AX (Nelms et al., 1998; Shiloh, 2003) . The MRN complex is composed of Mre11, Rad50 and Nbs1 proteins, which are involved in DNA repair by homologous recombination and nonhomologous end-joining. This complex is crucial for maintaining genomic integrity, illustrated by the fact that the cancer-prone syndromes ataxia-telangiectasialike disorder (ATLD) and Nijmegen Breakage Syndrome (NBS) result from a lack of functional Mre11 and Nbs1, respectively (Taalman et al., 1983; Maser et al., 1997; Shiloh, 1997; Carney et al., 1998; Stewart et al., 1999; D'Amours and Jackson, 2002) Loss of 53BP1 results in a defect in checkpoint activation in S phase and G2/M (DiTullio et al., 2002; Fernandez-Capetillo et al., 2002; Wang et al., 2002) . Phosphorylation of histone H2AX (gH2AX) occurs following a doublestrand break and is a sensitive marker for DNA damage (Rogakou et al., 1998; Paull et al., 2000) . The Atm kinase, mutated in the rare disorder ataxia telangiectasia (AT), phosphorylates many components of the DNA damage response, including Mre11, Nbs1, 53BP1, Chk2 and p53 (Shiloh, 2003) .
Previous studies demonstrated a requirement for Nbs1 in E2F1-mediated p53-dependent apoptosis (Powers et al., 2004; Rogoff et al., 2004) . We now show that the MRN complex, along with the 53BP1 and gH2AX DNA damage recognition factors, relocalize into discrete foci following deregulation of E2F1, whereas E2F3a, another transactivating E2F, does not alter the nuclear location of the recognition factors. A consequence of these events is the activation of a cell cycle checkpoint mediated by Nbs1, 53BP1, p53, and p21 WAF1/CIP1 . Lastly, we find that the checkpoint is the predominant signal generated by deregulated E2F1 and that abrogating the checkpoint increases both the rate and extent of apoptosis.
Results

Deregulation of E2F1 leads to Mre11 relocalization into discrete foci
The MRN complex can be visualized as nuclear foci that form in response to certain types of DNA damage (Maser et al., 1997; Carney et al., 1998; Nelms et al., 1998; D'Amours and Jackson, 2002) . E2F1 overexpression in normal human dermal fibroblasts (NHFs) led to relocalization of Mre11 to nuclear foci, while no foci were observed following E2F3a expression (Figure 1a and b). However, overexpression of E2F1 or E2F3a resulted in an increase in phospho-serine-15 p53 E2F1 induces MRN foci and a cell cycle checkpoint FM Frame et al (Figure 1c ), a modification mediated by Atm (Powers et al., 2004; Rogoff et al., 2004) . Both E2F1 and E2F3a expression resulted in activation of Atm as measured by the increase in the phospho-serine-1981 form of Atm (Figure 1d ) suggesting that Atm activation is not a unique event associated with Mre11 relocalization. Mre11 foci formation correlated with an E2F1-specific increase in phospho-serine-20 p53 ( Figure 1c ) and a subsequent induction of apoptosis raising the possibility that foci formation precedes apoptosis, which occurs 48-72 h later (Figures 1e and 6 ). These results indicate that foci formation and apoptosis are unique features of E2F1.
We next wanted to determine if endogenous E2F1 could also induce Mre11 relocalization. We modeled deregulation of endogenous E2F1 using two methods. First, we used a recombinant adenovirus encoding the human papillomavirus (HPV) E7 gene (AdE7). E7 binds to and stimulates the degradation of all three Rb family members thus leading to the derepression of endogenous E2F proteins (Munger and Howley, 2002) . Second, we used an siRNA targeted to Rb mRNA (siRb), which results in a reduction in Rb protein levels and derepression of endogenous E2F proteins (Pickering and Kowalik, 2005) .
Rb inactivation by E7 or siRb induced relocalization of Mre11 to nuclear foci ( Figure 2 ). To test if E7-induced Mre11 foci were dependent on E2F1, HEL fibroblasts were transfected with siE2F1, siE2F3 or a nonspecific siRNA and infected with AdE7 or a control virus. In the presence of siE2F1, E7 expression generated approximately six-fold less cells with foci than with a nonspecific siRNA (Figure 2b ). Transfection with siE2F3 showed no difference in the percentage of cells with foci relative to control. Immunoblots showing levels of E2F and Rb protein depletion are presented in Figure 2c and e. These studies indicate that deregulation of E2F, specifically E2F1, results in Mre11 foci formation.
E2F1 induces foci similar to irradiation induced foci (IRIF)
Following DNA damage, Mre11 foci colocalize with and require Nbs1 for MRN complex formation (Maser et al., 1997; Carney et al., 1998; Nelms et al., 1998; Lombard and Guarente, 2000; Wu et al., 2000; Maser et al., 2001) . Similarly, we found that Nbs1 and Mre11 colocalized to nuclear foci following E2F1 expression and that Mre11 relocalization required Nbs1 (Figure 3a and b). DNA damage induces relocalization of other DNA damage response proteins, including gH2AX and 53BP1 (Rogakou et al., 1998; Anderson et al., 2001; Kobayashi et al., 2002) . Expression of E2F1 induced relocalization of gH2AX and 53BP1 to nuclear foci (Figure 3c and d). DNA damage foci form independently of Atm (Mirzoeva and Petrini, 2001 ). Likewise, E2F1 induced Mre11 foci in cells lacking Atm ( Figure 3e ). Thus, Atm activation or even the presence of Atm is not necessary for foci formation although Atm is required for E2F1-mediated apoptosis and downstream signaling after foci formation (Shiloh, 2003;  E2F1 induces MRN foci and a cell cycle checkpoint FM Frame et al Rogoff et al., 2004) . These results suggest that deregulated E2F1 leads to foci similar to the irradiationinduced foci observed following genotoxic stress.
MRN foci formation is not directly associated with E2F1-mediated induction of DNA replication MRN complex formation has also been observed during S phase when no extrinsic DNA damaging agent has been present and the complexes are found at E2F binding elements near origins of DNA replication (Maser et al., 2001) . Since E2F1 and E2F3a have been described to induce S phase in rodent fibroblasts (Johnson et al., 1993; Kowalik et al., 1995; DeGregori et al., 1997) , we determined if the observed foci could be attributed to the MRN complex localizing to sites of DNA replication (Maser et al., 2001) . Examination of the subset of cells incorporating BrdU following E2F1 expression resulted in no evidence for colocalization of Mre11 and BrdU. In fact, there were very few BrdU positive cells following expression of E2F1 (Figure 4a ). We used two E2F mutants to further assess the relationship between S phase induction by E2F1 and Mre11 foci formation. The E2F1 e132 mutant is unable to bind DNA or induce S phase in cells (Johnson et al., 1993) . E2F1 1-283 lacks much of the C-terminal half of E2F1 including the transactivation and Rb binding domains (Cress and Nevins, 1994) . Moreover, E2F1 1-283 also lacks an E2F1-Nbs1 interacting region (Maser et al., 2001 ) that might influence MRN foci formation. Expression of either E2F1 e132 or E2F1 1-283 resulted in MRN relocalization similar to expression of full-length E2F1 (Figure 4b and c) . These results suggest that MRN foci formation is independent of E2F1-induced DNA replication.
E2F1 induces a cell cycle checkpoint dependent on foci forming proteins and the p53/p21 WAF1/CIP1 pathway Although expression of E2F1 or E2F3a in rodent cells can promote S phase entry (Johnson et al., 1993; Kowalik et al., 1995; DeGregori et al., 1997) , E2F1 overexpression is unable to induce S phase in serum deprived, normal human and mouse fibroblasts (Lomazzi et al., 2002) and can lead to senescence in human fibroblasts (Dimri et al., 2000) . Given that we observed few BrdU positive cells following E2F1 expression in random cycling cells, we tested the effect of E2F1 on cell cycle progression in synchronized human fibroblasts. When serum-containing growth medium was added to starved HELs following transduction with control virus or virus encoding E2F3a, cells underwent DNA replication as measured by BrdU incorporation. In contrast, starved cells transduced with virus encoding E2F1 followed by serum stimulation did not replicate their DNA (Figure 5a) .
Analysis of cellular DNA content showed that B86% of serum-starved cells retained a 2N DNA content with B12% of cells having 4N or intermediate DNA amounts (Figure 5b and c) . Likewise, most (B79%) of the E2F1 expressing cells that were serum stimulated had a 2N DNA content, with B20% of these cells found to have intermediate or 4N DNA contents. Therefore, only 8% of these cells progressed out of the 2N compartment relative to the serum-starved control. This result is in contrast to those observed with serumstimulated cells or cells that were both serum stimulated and expressing E2F3a, where B38 or B29% of cells, respectively, had a >2N DNA content relative to the serum-starved control. Thus, deregulation of E2F1 expression can activate a G1 checkpoint that blocks the transition from G0 to S phase. Activating a cell cycle checkpoint in late G1/S phase can involve Atm and downstream signaling proteins (Kastan and Lim, 2000) . However, E2F1 and E2F3a were both able to activate Atm (Figure 1d ), suggesting that this is not sufficient to cause the E2F1-induced checkpoint. Loss of either Nbs1 or 53BP1 abrogates activation of DNA damage induced cell cycle checkpoints (DiTullio et al., 2002; Wang et al., 2002) . We used siRNAs to reduce the levels of Nbs1 or 53BP1 (Figure 5e ) and found that depletion of either protein partially alleviated the E2F1 checkpoint (Figure 5d ). These results suggest that Nbs1 and 53BP1 play a role in blocking the G0 to S phase progression following E2F1 expression.
In the DNA damage response, Nbs1 and 53BP1 function upstream of p53 (Jongmans et al., 1997; Wang et al., 2002) . Depletion of p53 with sip53 partially alleviated the E2F1-induced checkpoint (Figure 5d and e). The p21 WAF1/CIP1 CDK inhibitor is responsible for mediating p53-dependent checkpoints (el-Deiry et al., 1993 (el-Deiry et al., , 1994 Bartek and Lukas, 2001a, b) . An siRNA that reduces p21 WAF1/CIP1 levels also partially relieved the E2F1 checkpoint (Figure 5d and e) . In addition, expression of E2F1 resulted in an accumulation of p21 WAF1/CIP1 peaking at 24 h (Figure 5f ). Expression of E2F3a, which did not activate a cell cycle checkpoint, also resulted in an increase of p21 WAF1/CIP1 levels but to considerably lower levels than that observed in the E2F1 samples. Since p21 WAF1/CIP1 is a transcriptional target of p53 (el-Deiry et al., 1993 (el-Deiry et al., , 1994 , we determined if p53 was responsible for the observed induction of p21 WAF1/CIP1 expression. Depletion of p53 reduced the ability of E2F1 to promote p21 WAF1/CIP1 accumulation (Figure 5g ). Collectively, these results suggest that expression of E2F1 activates a cell cycle checkpoint in part through its ability to affect foci forming proteins to stimulate a p53-dependent accumulation of p21
. These results are consistent with the report by Lomazzi et al. (2002) , where it was shown that E2F1 alone could not induce S phase in serum-starved fibroblasts except in the absence of p14ARF, p53 or p21
The E2F1-mediated checkpoint response is antiapoptotic E2F1 expression resulted in p21 WAF1/CIP1 accumulation and a cell cycle arrest by 24 hpi, suggesting that E2F1 activates a checkpoint that is prior to apoptosis, which is nominal through 72 hpi and pronounced at 96 hpi ( Figure 6 ). Treatment of cells with si53BP1 or sip21, which are not components of the apoptosis pathway, resulted in an increase in both the rate and the extent of E2F1-mediated apoptosis (Figure 6 ). Since Nbs1 and p53 contribute to both the checkpoint and apoptosis pathways altering the levels of these proteins could not be included in this assay (Rogoff et al., 2004) . These results suggest that E2F1 activates a cell cycle checkpoint that delays the induction of apoptosis.
Discussion
In this study, we describe E2F1-induced relocalization of the MRN complex, 53BP1 and gH2AX into discrete foci that have similarities to foci observed following DNA damage. Importantly, relocalization of Mre11 occurs not only through ectopic expression of E2F1 but also specifically through deregulation of endogenous protein. Moreover, by using different methodologies including overexpression, viral oncoprotein transduction, and RNAi, we ensure that the observations were not due to nuances associated with a particular approach. A consequence of stimulating foci forming proteins by E2F1 is the activation of a cell cycle checkpoint pathway through p53/p21 WAF1/CIP1 that is dominant to E2F1-mediated apoptosis. These data suggest that initially following E2F1 deregulation, a G1 checkpoint predominates and that continued activation of E2F1 or inactivation of the checkpoint favors apoptosis (Figure 7) . 
E2F1 induces MRN foci and a cell cycle checkpoint FM Frame et al
The question remains as to why these foci form following expression of E2F1. One possibility is that deregulated E2F1 induces stalled replication forks that activate checkpoint and apoptosis signals. However, E2F1 mutants that do not stimulate DNA replication still relocalized MRN proteins (Figure 4b and c) and E2F3a, which can induce DNA replication, does not form MRN foci, signal the checkpoint or apoptosis (Figures 1e and 5a-c) . Moreover, stalled replication forks stimulate an ATR-Chk1 response, a pathway not activated by E2F1 (Rogoff et al., 2004) . Another possibility is that E2F1 might serve to anchor MRN proteins at DNA via its interaction with Nbs1 (Maser et al., 2001 ). However, expression of an E2F1 mutant lacking this Nbs1 binding region still results in the appearance of MRN foci. We propose that deregulation of E2F1 leads to an accumulation of DNA breaks (Pickering and Kowalik, 2005) that generates the checkpoint and apoptosis responses.
The significance of our findings is perhaps best represented in recent studies that find evidence of a DNA damage response and checkpoint activation in tumor samples and precancerous lesions (Bartkova et al., 2005; Gorgoulis et al., 2005) . The authors hypothesize that in the initial stages of cancer progression, cells experience a stress stimulus and respond by activating the DNA damage pathway, which might prevent or at least delay tumor progression. We propose that these observations may be due to the deregulation of the Rb/E2F pathway, and specifically E2F1. Taken together, our findings and these studies suggest that loss of Rb/E2F control must be coupled with abrogation of both the E2F1-induced checkpoint and apoptosis pathways for a cell to progress to a cancerous lesion.
Materials and methods
Cell culture
NHFs (GM00316B), NBS dermal fibroblasts (GM07166A) and AT dermal fibroblasts (GM05823C) were obtained from Coriell Cell Repositories, Camden, NJ, USA. Human embryonic lung fibroblasts (HELs; GM01604) were purchased from ATCC. Cells were cultured as recommended by each manufacturer, typically DMEM media with 10% fetal bovine serum (FBS).
Adenovirus vectors
Recombinant adenoviruses encoding E2F1, E2F3a, E7 and E2F1 e132 have been previously described (Kowalik et al., 1995; Schwarz et al., 1995; DeGregori et al., 1997; Rogoff et al., 2004) . An adenovirus encoding the E2F1 1-283 truncated mutant was generated using the AdEasy system (He et al., 1998) . Control viruses encode either an empty expression cassette or b-galactosidase. Infection with control virus had no effect on parameters tested relative to mock infection. Propagation and titering of adenoviruses was carried out as described (Castillo et al., 2000) Virus infections were carried out at a multiplicity of infection (MOI) of 1000 in NHFs and 250 in HELs unless stated otherwise. The infection efficiency is lower in the NHFs relative to the HELs, and so a higher MOI was used for the former.
Immunofluorescence
Cells were plated at 3000 cells/cm 2 on glass coverslips that were pretreated with 40% HCl for 2 min followed by a 5 min, 70% ethanol wash. Cells were infected with recombinant adenoviruses and at 24 hpi cells were washed three times with PBS and fixed for 15 min and processed as described (Mirzoeva and Petrini, 2001) . Fixed cells were blocked in 10% FBS for 1 h at room temperature and incubated with Mre11 (Genetex) Nbs1, 53BP1 (Novus Biologicals) or gH2AX (Upstate Biotechnology) antibodies. Bound antibodies were detected using FITC or Rhodamine Red-X conjugated secondary antibodies 
Immunoblot analysis
Whole-cell extracts were harvested and processed as previously described (Rogoff et al., 2004) . Antibodies used were p53 protein (Oncogene Research Products), phospho-serine-15 and phospho-serine-20 forms of p53 (Cell Signaling Technologies), 53BP1 and Nbs1 (Novus Biologicals), Atm and phosphoserine-1981 Atm (Rockland Immunochemicals), E2F3 (Santa Cruz), p21 (Santa Cruz), E2F1 (Neomarkers) and Rb (Calbiochem). Actin (Santa Cruz) was used as a protein loading control. Immunoreactive proteins were detected with a chemiluminescence kit (Perkin-Elmer).
Apoptosis analysis
Cells were plated in 24-well plates at 1 Â 10 4 cells per well. Cells were infected with recombinant adenovirus and harvested at the time indicated and centrifuged at 500 Â g for 10 min at 41C, lysed and the Cell Death Detection ELISAplus assay performed (Roche). The y-axis represents extent of apoptosis relative to control, which is defined as 1. Error bars represent standard deviations calculated from the experiment performed in triplicate.
BrdU incorporation assay
NHFs were plated at 3000 cells/cm 3 and synchronized in G0 by incubating for 48 h in media containing 0.1% serum. Immediately following infection, media containing 10% serum and 10 mM BrdU was added to cells. To detect DNA replication in unsynchronized populations, cells were pulsed with 10 mM BrdU for 3 h prior to harvesting at 24 hpi. Cells were then fixed and permeabilized using the same protocol for immunofluorescence (see above). Following permeabilization, cells were treated as described previously (Maser et al., 2001) . Cells were blocked in 10% FBS and incubated for 1 h with BrdU antibody (Immunologicals Direct). Bound antibody was detected using a Rhodamine Red-X conjugated secondary antibody. In total, >200 cells were counted per sample.
Propidium iodide staining and flow cytometry analysis HELs were plated at 12 500 cells/cm 3 . Cells were synchronized in G0 by incubating for 48 h in media containing 0.1% serum. Immediately following infection, media containing 10% serum was added to cells. Cells were harvested 24 hpi, fixed, incubated with propidium iodide and analyzed for DNA content as previously described (Kowalik et al., 1995; Rogoff et al., 2002) . Flow cytometric analysis was performed by the U. Mass. Flow Cytometry Facility. Data analysis was carried out using FlowJo (Tree Star Inc.). Results are presented as percent cells in each cell cycle stage with the standard deviation of the experiment performed in triplicate.
RNA interference siRNAs were generated by Qiagen. siRNAs were transfected at 50-100 nM using Lipofectamine 2000 (Invitrogen). Transfection conditions for individual siRNAs were optimized. The nonspecific siRNA (ns) had no effect on parameters tested relative to mock transfection. siRNAs used in this study: ns (5 0 -TTTTTTTCCCCAAAGGGGG-3 0 ), siE2F1 (5 0 -AAGGCC CGATCGATGTTTTCC-3 0 ), siE2F3 (5 0 -AGCGGUCAUCAG UACCUCU-3 0 ), siRb (5 0 -UUCCUCCACACACUCCAGU-3 0 ), sip21a (5 0 -AGGCCCGCUCUACAUCUUC-3 0 ), sip21b (5 0 -CUAGGCGGUUGAAUGAGAG-3 0 ), siNbs1a (5 0 -AUCAU GCUGUGUUAACUGC-3 0 ), siNbs1b (5 0 -AUGUUGAUCU GUCAGGACG-3 0 ), sip53 (5 0 -GCAUGAACCGGAGGCC CAU-3 0 ), si53BP1 (5 0 -GCCAGGUUCUAGAGGAUGAUU-3 0 ).
